Cardinal Health announced that it has completed the acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for $6.1 billion. The acquisition was funded with a combination of $4.5 billion in new senior unsecured notes, existing cash and borrowings under our existing credit arrangements. “This business provides our customers with more product offerings and includes some well-established …

bioMérieux, a world leader in the field of in vitro diagnostics announced that VITEK® MS, its MALDI-TOF1 Mass Spectrometry System for rapid pathogen identification, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded identification of mycobacteria, Nocardia and moulds. This database includes more than 15,000 distinct strains to provide extremely high accuracy and, for …

Bracco Diagnostics Inc. announced the U.S. Food and Drug Administration (FDA) approved VARIBAR NECTAR (barium sulfate) oral suspension for use in modified barium swallow (MBS) examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients with known or suspected swallowing disorders. Trouble with swallowing is a frequent cause of morbidity and disability in all age …

TTP plc announces that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers. The new offering will include comprehensive product development services that span instrumentation, consumables and reagents. The partnership is focused on supporting customers in the molecular diagnostic and wider life science space to rapidly transition ideas into commercially successful products. The services will …

Agfa HealthCare announces that it has received FDA 510(k) clearance for the XERO Xtend functionalities of the Enterprise Imaging zero-footprint viewer. XERO Xtend adds 3D processing and advanced clinical applications to the XERO Viewer. It is now FDA-cleared for diagnostic viewing on desktop devices.1 The release data for 510K cleared XERO Xtend will be communicated by Agfa HealthCare’s regional sales …

Beckman Coulter Diagnostics introduces its DxONE information management solutions, an integrated system of technologies and capabilities, designed to ease data access and usability. DxONE is designed in response to the increasing challenges faced by laboratory technicians to expedite result times, reduce costs, maneuver personnel shortages and navigate network consolidations. The suite of next-generation technologies applies cloud-computing to provide remote-access functionality …

Roche announced the commercial availability of the AVENIO Millisect System, a tissue dissection instrument that utilizes an automated digitally assisted process to reliably and efficiently isolate clinically relevant cells from formalin-fixed paraffin-embedded (FFPE) tissue slides. The AVENIO Millisect System addresses challenges inherent in today’s tissue dissection practice in the clinical lab workspace where manual dissection lacks consistency and precision, and …

Blue Earth Diagnostics announced that they have entered into an exclusive manufacturing and distribution agreement for the supply of Blue Earth Diagnostics’ PET imaging product Axumin™ (fluciclovine (18F)) in Ireland. M2i, through their Dublin PET manufacturing site, will bring Axumin to market in the Republic of Ireland and in Northern Ireland. Axumin is indicated in Europe for use in PET …

Roxwood Medical Inc. announced it has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the United States. “This partnership with Abbott’s vascular business is a major milestone for Roxwood that allows far more patients to benefit from our catheter portfolio used during complex coronary procedures,” said Mehrdad Farhangnia, chief executive officer, Roxwood Medical. “We have …

Vertera Spine announced the COALESCE™ Lumbar Interbody Fusion Device has received U.S. Food and Drug Administration (FDA) 510(k) clearance for use in anterior, transforaminal, posterior, and lateral lumbar interbody fusion procedures. COALESCE features Vertera Spine’s novel proprietary porous PEEK biomaterial and is the second porous PEEK device to receive FDA clearance behind Vertera Spine’s COHERE® Cervical Interbody Fusion Device. Vertera …